Inosita Plus XR 50/1000mg Tablet

Inosita Plus XR 50/1000mg Tablet combines Sitagliptin and Metformin as its active ingredients. It is a fixed-dose combination medication used to manage type 2 diabetes mellitus. Sitagliptin belongs to the class of medications called dipeptidyl peptidase-4 (DPP-4) inhibitors, while Metformin is a biguanide antidiabetic agent. Inosita Plus XR 50/1000mg Tablet helps control blood sugar levels by increasing insulin release and decreasing glucose production in the liver.

Active Ingredients:

• Sitagliptin: A DPP-4 inhibitor that helps regulate blood sugar levels by increasing insulin secretion and decreasing glucagon levels after meals.
• Metformin: A biguanide antidiabetic medication that improves insulin sensitivity, reduces glucose production in the liver, and decreases intestinal absorption of glucose.

Uses:

• Type 2 Diabetes Mellitus: Inosita Plus XR 50/1000mg Tablet is indicated for the management of type 2 diabetes mellitus in adults, either as initial therapy or in combination with other antidiabetic medications.

Dosage and Administration:

• The dosage of Inosita Plus XR 50/1000mg Tablet may vary depending on individual patient factors, such as age, renal function, and glycemic control.
• It is usually taken orally, once daily, with meals, as directed by a healthcare professional.
• Swallow the tablet whole with a full glass of water. Do not crush, chew, or break the tablet unless instructed otherwise.
• Follow the prescribed dosage regimen and continue taking the medication regularly to achieve optimal glycemic control.

Precautions:

• Before taking Inosita Plus XR 50/1000mg Tablet, inform your healthcare provider about any existing medical conditions, allergies, or medications you are taking.
• Use caution in individuals with renal impairment, as Metformin is excreted by the kidneys. Dosage adjustments may be necessary based on renal function.
• Monitor blood sugar levels regularly, especially during the initial weeks of treatment or during periods of dose adjustment.

Side Effects:

• Common side effects of Inosita Plus XR 50/1000mg Tablet may include diarrhea, nausea, vomiting, abdominal discomfort, flatulence, headache, or upper respiratory tract infection.
• Contact your healthcare provider if you experience any severe or persistent side effects while taking Inosita Plus XR 50/1000mg Tablet.

Storage:

• Store Inosita Plus XR 50/1000mg Tablet at room temperature, away from moisture, heat, and direct sunlight.
• Keep the tablets out of reach of children and pets.

FAQs:

1. How does Inosita Plus XR 50/1000mg Tablet work? Inosita Plus XR 50/1000mg Tablet combines Sitagliptin and Metformin, which work together to control blood sugar levels by increasing insulin release, decreasing glucose production in the liver, and improving insulin sensitivity.
2. When should I take Inosita Plus XR 50/1000mg Tablet? Inosita Plus XR 50/1000mg Tablet is usually taken orally, once daily, with meals. Follow the prescribed dosage regimen for optimal glycemic control.
3. Can Inosita Plus XR 50/1000mg Tablet be used alone or in combination with other antidiabetic medications? Inosita Plus XR 50/1000mg Tablet can be used as monotherapy or in combination with other antidiabetic medications, depending on individual patient needs and treatment goals.
4. What are the common side effects of Inosita Plus XR 50/1000mg Tablet? Common side effects may include gastrointestinal symptoms such as diarrhea, nausea, vomiting, and abdominal discomfort. These side effects are usually mild and transient.
5. Is regular monitoring of blood sugar levels necessary while taking Inosita Plus XR 50/1000mg Tablet? Yes, regular monitoring of blood sugar levels is essential while taking Inosita Plus XR 50/1000mg Tablet to assess treatment effectiveness and adjust the dosage as needed to achieve optimal glycemic control.